bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic
Go back to bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic| (NASDAQ: BIAF) | Delayed: 3.57 -0.09 (2.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.66 | 52 Week High | $ | |||
| Open | $3.68 | 52 Week Low | $ | |||
| Day High | $3.69 | P/E | N/A | |||
| Day Low | $3.54 | EPS | $ | |||
| Volume | 55,458 | |||||
| (NASDAQ: BIAFW) | Delayed: 0.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.32 | 52 Week High | $ | |||
| Open | $0.32 | 52 Week Low | $ | |||
| Day High | $0.32 | P/E | N/A | |||
| Day Low | $0.32 | EPS | $ | |||
| Volume | 905,781 | |||||



